Vicarious Surgical Ownership
| RBOT Stock | USD 5.75 0.10 1.71% |
Shares in Circulation | First Issued 2020-03-31 | Previous Quarter 5.9 M | Current Value 5.9 M | Avarage Shares Outstanding 4.7 M | Quarterly Volatility 1 M |
Vicarious | Build AI portfolio with Vicarious Stock |
Vicarious Stock Ownership Analysis
About 20.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.43. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Vicarious Surgical recorded a loss per share of 10.07. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 13th of June 2024. Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts. Vicarious Surgical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 153 people. To find out more about Vicarious Surgical contact Stephen From at 617 868 1700 or learn more at https://www.vicarioussurgical.com.Besides selling stocks to institutional investors, Vicarious Surgical also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Vicarious Surgical's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Vicarious Surgical's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Vicarious Surgical Quarterly Liabilities And Stockholders Equity |
|
Vicarious Surgical Insider Trades History
About 20.0% of Vicarious Surgical are currently held by insiders. Unlike Vicarious Surgical's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Vicarious Surgical's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Vicarious Surgical's insider trades
Vicarious Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Vicarious Surgical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vicarious Surgical backward and forwards among themselves. Vicarious Surgical's institutional investor refers to the entity that pools money to purchase Vicarious Surgical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2025-06-30 | 16.4 K | Bridgeway Capital Management, Llc | 2025-06-30 | 11.8 K | Renaissance Technologies Corp | 2025-06-30 | 11.1 K | Royal Bank Of Canada | 2025-06-30 | 5.1 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 1.8 K | Advisor Group Holdings, Inc. | 2025-06-30 | 1.6 K | Hanson Mcclain Inc | 2025-06-30 | 1 K | Hughes Financial Services, Llc | 2025-06-30 | 333 | Future Financial Wealth Managment Llc | 2025-06-30 | 210 | Vk Services Llc | 2025-06-30 | 965.2 K | Ddd Partners, Llc | 2025-06-30 | 207.1 K |
Vicarious Surgical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vicarious Surgical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vicarious Surgical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vicarious Surgical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Vicarious Surgical Outstanding Bonds
Vicarious Surgical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vicarious Surgical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Vicarious bonds can be classified according to their maturity, which is the date when Vicarious Surgical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| VICI 495 15 FEB 30 Corp BondUS925650AC72 | View | |
| VICI 5125 15 MAY 32 Corp BondUS925650AD55 | View | |
| VICI 5625 15 MAY 52 Corp BondUS925650AE39 | View | |
| VICI 575 01 FEB 27 Corp BondUS92564RAJ41 | View | |
| VICI 3875 15 FEB 29 Corp BondUS92564RAL96 | View | |
| VICI 45 15 JAN 28 Corp BondUS92564RAK14 | View | |
| VICI Properties 4125 Corp BondUS92564RAE53 | View |
Vicarious Surgical Corporate Filings
| 15th of October 2025 Other Reports | ViewVerify | |
| 8th of October 2025 Other Reports | ViewVerify | |
F3 | 2nd of October 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 25th of September 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vicarious Stock Analysis
When running Vicarious Surgical's price analysis, check to measure Vicarious Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicarious Surgical is operating at the current time. Most of Vicarious Surgical's value examination focuses on studying past and present price action to predict the probability of Vicarious Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicarious Surgical's price. Additionally, you may evaluate how the addition of Vicarious Surgical to your portfolios can decrease your overall portfolio volatility.